默沙东将在2025 ASCO年会上发布新数据

默沙东中国
27 May

默沙东将在2025 ASCO年会上发布新数据,展示来自广阔且差异化产品组合和在研管线中创新治疗方案的进展Zilovertamab vedotin和sacituzumabtirumotecan研究数据发布,展现默沙东抗体偶联药物在研管线进展帕博利珠单抗和贝组替凡的随访数据以及帕博利珠单抗用于部分早期癌症的全新或更新数据发布该下一代CD3/CD19 双特异性抗体对于B细胞恶性肿瘤和自身免疫性疾病具有...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10